Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-9 of 9 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Daratumumab to Treat Active Lupus Nephritis

    Rochester, MN

  2. PRA023 in Subjects with Systemic Sclerosis Associated with Interstitial Lung Disease

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

    Scottsdale/Phoenix, AZ

  4. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

    Jacksonville, FL

  5. A Study to Enroll Patients of Rheumatic Diseases and First-degree Relatives in a Biobank

    Rochester, MN, Rochester, MN

  6. The ANSWERS Study

    Rochester, MN

  7. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis

    Rochester, MN

  8. Biomarkers in Autoimmune and Inflammatory Diseases

    Rochester, MN

  9. Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

    Rochester, MN

.

Mayo Clinic Footer